Geoffrey Beran Rose - Jan 22, 2024 Form 4 Insider Report for Pulmonx Corp (LUNG)

Signature
/s/ Lauren Cristina, Attorney-in-Fact
Stock symbol
LUNG
Transactions as of
Jan 22, 2024
Transactions value $
-$15,546
Form type
4
Date filed
1/24/2024, 05:41 PM
Previous filing
Dec 27, 2023
Next filing
Feb 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale -$15.5K -1.18K -0.48% $13.13 244K Jan 22, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2023.